Charles River Laboratories CRL Business Sale Proceeds
Business Sale Proceeds at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's business sale proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's business sale proceeds?
- Charles River Laboratories (CRL) reported business sale proceeds of $60.1M in Q1 2026.
- How has Charles River Laboratories's business sale proceeds changed year-over-year?
- Charles River Laboratories's business sale proceeds increased by 244.6% year-over-year, from $17.44M to $60.1M.
- What is the long-term trend for Charles River Laboratories's business sale proceeds?
- Over 3 years (2021 to 2024), Charles River Laboratories's business sale proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $122.69M to $0.
- What does business sale proceeds mean?
- Cash received from selling parts of the business or entire business units.
- How do you interpret business sale proceeds?
- An increase indicates successful divestiture of non-core assets, while a decrease suggests a focus on organic growth or lack of divestment activity.
- How does business sale proceeds compare across companies?
- Varies significantly based on corporate restructuring cycles and M&A strategy.